Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 EUR)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 21,515 Less Arrow 5,178 Less Arrow 0
Financial expenses 1,673 Less Arrow 206 More Arrow 258
Earnings before taxes -29,022 More Arrow -15,143 Less Arrow -17,916
EBITDA -27,105 More Arrow -14,268 Less Arrow -16,463
Total assets 58,896 More Arrow 62,050 More Arrow 67,315
Current assets 41,609 More Arrow 46,146 More Arrow 54,856
Current liabilities 29,430 Less Arrow 21,258 More Arrow 21,479
Equity capital 15,441 More Arrow 38,181 More Arrow 42,216
- share capital 602 Less Arrow 554 Less Arrow 549
Employees (average) 89 Less Arrow 68 Less Arrow 50

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 26.2% More Arrow 61.5% More Arrow 62.7%
Turnover per employee 242 Less Arrow 76 Less Arrow 0
Profit as a percentage of turnover -134.9% Less Arrow -292.4%
Return on assets (ROA) -46.4% More Arrow -24.1% Less Arrow -26.2%
Current ratio 141.4% More Arrow 217.1% More Arrow 255.4%
Return on equity (ROE) -188.0% More Arrow -39.7% Less Arrow -42.4%
Change turnover 16,322 Less Arrow 5,178 Less Arrow 0
Change turnover % 314%
Chg. No. of employees 21 Less Arrow 18 Less Arrow 11
Chg. No. of employees % 31% More Arrow 36% Less Arrow 28%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.